Cargando…

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging

The receptor for advanced glycation end-products (RAGE) recognizes several ligands involved in inflammatory diseases. Two circulating soluble isoforms exist: esRAGE derived from alternative splicing and cRAGE generated by the membrane-bound RAGE (FL-RAGE) proteolysis. Together, esRAGE and cRAGE cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scavello, Francesco, Zeni, Filippo, Tedesco, Calogero C., Mensà, Emanuela, Veglia, Fabrizio, Procopio, Antonio Domenico, Bonfigli, Anna Rita, Olivieri, Fabiola, Raucci, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461165/ https://www.ncbi.nlm.nih.gov/pubmed/30903794 http://dx.doi.org/10.18632/aging.101860

Ejemplares similares

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

The microRNA-34a-Induced Senescence-Associated Secretory Phenotype (SASP) Favors Vascular Smooth Muscle Cells Calcification
por: Zuccolo, Estella, et al.
Publicado: (2020)

Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study
por: Sabbatinelli, Jacopo, et al.
Publicado: (2022)

Effects of RAGE Deletion on the Cardiac Transcriptome during Aging
por: Scavello, Francesco, et al.
Publicado: (2022)

The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries
por: Salehi, Mitra, et al.
Publicado: (2022)

The Receptor for Advanced Glycation End-Products (RAGE) Is Only Present in Mammals, and Belongs to a Family of Cell Adhesion Molecules (CAMs)
por: Sessa, Luca, et al.
Publicado: (2014)

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009)

Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases
por: Lee, Eun Ji, et al.
Publicado: (2013)

Soluble Forms of the Receptor for Advanced Glycation Endproducts (RAGE) in Periodontitis
por: Detzen, Laurent, et al.
Publicado: (2019)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

The Mouse-Specific Splice Variant mRAGE_v4 Encodes a Membrane-Bound RAGE That Is Resistant to Shedding and Does Not Contribute to the Production of Soluble RAGE
por: Di Maggio, Stefania, et al.
Publicado: (2016)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss
por: Popp, Collin J, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
por: Song, Juhyun, et al.
Publicado: (2014)

SUN-LB131 Association of Receptor for Advanced Glycation End Product (RAGE) Gene Polymorphisms & Serum Levels of Soluble RAGE (sRAGE) With Metabolic Syndrome (MS) in Mexican Population
por: Gonzalez-Guerrero, Diana Elizabeth, et al.
Publicado: (2020)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Age dependent accumulation patterns of advanced glycation end product receptor (RAGE) ligands and binding intensities between RAGE and its ligands differ in the liver, kidney, and skeletal muscle
por: Son, Myeongjoo, et al.
Publicado: (2017)

Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients
por: Jung, Eul Sik, et al.
Publicado: (2017)

Prognostic value of soluble ST2, high-sensitivity cardiac troponin, and NT-proBNP in type 2 diabetes: a 15-year retrospective study
por: Sabbatinelli, Jacopo, et al.
Publicado: (2022)

Age-related modulation of plasmatic beta-Galactosidase activity in healthy subjects and in patients affected by T2DM
por: Spazzafumo, Liana, et al.
Publicado: (2017)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

The role of receptor for advanced glycation endproducts (RAGE) in infection
por: van Zoelen , Marieke AD, et al.
Publicado: (2011)

The Role of Receptor for Advanced Glycation Endproducts (RAGE) in Infection
por: van Zoelen, M. A. D., et al.
Publicado: (2011)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
por: Kim, Taehee, et al.
Publicado: (2023)

MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications
por: Olivieri, Fabiola, et al.
Publicado: (2015)

The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling
por: Reed, James C., et al.
Publicado: (2020)

Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
por: Drake, Lindsey R., et al.
Publicado: (2020)

Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes
por: Prattichizzo, Francesco, et al.
Publicado: (2015)

The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes
por: Erusalimsky, Jorge D.
Publicado: (2021)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
por: Nowak, Agnieszka, et al.
Publicado: (2021)

Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
por: Deo, Permal, et al.
Publicado: (2023)

Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
por: El-Far, Ali H., et al.
Publicado: (2020)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

The mitomiR/Bcl-2 axis affects mitochondrial function and autophagic vacuole formation in senescent endothelial cells
por: Giuliani, Angelica, et al.
Publicado: (2018)

The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease
por: Chen, Der-Yuan, et al.
Publicado: (2015)

Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Dozio, Elena, et al.
Publicado: (2018)

Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study
por: Saputra, Gusti Noor Ramadany, et al.
Publicado: (2022)

Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
por: Peng, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u4bhl063h7d8khsb5v7gtnigm7